DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Wedbush Maintains Outperform on Clearside Biomedical, Raises Price Target to $5

Wedbush maintains Clearside Biomedical (NASDAQ:CLSD) with a Outperform and raises the price target from $3 to $5.

Benzinga · 01/27/2020 13:11

Wedbush maintains Clearside Biomedical (NASDAQ:CLSD) with a Outperform and raises the price target from $3 to $5.